| Literature DB >> 27034737 |
Woong Jin Bae1, U Syn Ha2, Jin Bong Choi2, Kang Sup Kim2, Su Jin Kim2, Hyuk Jin Cho2, Sung Hoo Hong2, Ji Youl Lee2, Zhiping Wang3, Sung Yeoun Hwang4, Sae Woong Kim1.
Abstract
Higher testicular temperature results in altered spermatogenesis due to heat-related oxidative stress. We examined the effects of decursin extracted from Angelica gigas Nakai on antioxidant activity in vitro and in a cryptorchidism-induced infertility rat model. TM3 Leydig cell viability was measured based on oxidative stress according to treatment. Either distilled water or AG 400 mg/kg of A. gigas extract was administered orally for 4 weeks after unilateral cryptorchidism was induced. After 1, 2, and 4 weeks, six rats from the control group and six rats from treatment group were sacrificed. Testicular weight, semen quality, antioxidant activities, nuclear factor erythroid 2-related factor 2 (Nrf2) protein, and mRNA expression of Nrf2-regulated genes were analyzed. Treatment with A. gigas extract (1) protected TM3 cells against oxidative stress in a dose-dependent manner, (2) improved the mean weight of the cryptorchid testis, (3) maintained sperm counts, motility, and spermatogenic cell density, (4) decreased levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) and increased levels of superoxide dismutase (SOD), (5) significantly increased Nrf2 and heme oxygenase-1 (HO-1), and (6) significantly decreased apoptosis. This study suggests that decursin extracted from A. gigas is a supplemental agent that can reduce oxidative stress by Nrf2-mediated upregulation of HO-1 in rat experimentally induced unilateral cryptorchidism and may improve cryptorchidism-induced infertility.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27034737 PMCID: PMC4807069 DOI: 10.1155/2016/5901098
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1HPLC chromatogram of the extract of Angelica gigas (a) and the standard solution (b). The peak with the arrow indicates decursin in standard compounds. A corresponding peak was seen in the extract HPLC chromatogram.
Primers used for real-time PCR.
| Gene | GenBank accession number | Sequence (5′→3′) | Length of DNA product (bp) |
|---|---|---|---|
| Beta-actin (ACTB) | NM_007393 | F: CTGTCCCTGTATGCCTCTG | 218 |
| R: ATGTCACGCACGATTTCC | |||
|
| |||
| Nuclear factor erythroid 2-related factor 2 | NM_010902 | F: CAGTGCTCCTATGCGTGAA | 109 |
| R: GCGGCTTGAATGTTTGTC | |||
|
| |||
| Heme oxygenase-1 | NM_010442 | F: ACAGATGGCGTCACTTCG | 128 |
| R: TGAGGACCCACTGGAGGA | |||
Figure 2Protective effects of Angelica gigas extract against H2O2. The cells were pretreated with the extract of Angelica gigas 2 hours before H2O2 treatment. p < 0.05 as compared with the control group.
Comparisons of parameters of the cryptorchid testicular health.
| Left testicular weight (g) | Sperm count (×106/g cauda) | % of motile spermatozoa | Spermatogenic cell density | ||
|---|---|---|---|---|---|
| 1st week | Control | 1.526 ± 0.225 | 350.2 ± 10.9 | 20.7 ± 3.3 | 0.343 ± 0.016 |
| AG | 1.612 ± 0.033 | 360.6 ± 14.0 | 22.5 ± 5.2 | 0.305 ± 0.031 | |
|
| |||||
| 2nd week | Control | 1.232 ± 0.165 | 240.2 ± 13.6 | 7.6 ± 2.3 | 0.275 ± 0.043 |
| AG | 1.515 ± 0.367 | 300.8 ± 12.5 | 14.5 ± 2.7 | 0.314 ± 0.074 | |
|
| |||||
| 4th week | Control | 0.858 ± 0.285 | 75.2 ± 18.2 | 5.7 ± 3.1 | 0.154 ± 0.028 |
| AG | 1.433 ± 0.634 | 310.5 ± 14.7 | 13.2 ± 8.2 | 0.269 ± 0.052 | |
Data show the mean ± SD AG, the extract of Angelica gigas treatment.
p < 0.05 as compared with the control group at the same period of time.
Figure 3Time-dependent histopathological findings of left testis (haematoxylin and eosin stain). Scale bars shown in each figure represent 100 μm. AG, the extract of Angelica gigas treatment.
Figure 4Comparison of the expression levels of SOD (a) and 8-OHdG (b). AG, the extract of Angelica gigas treatment. p < 0.05 as compared with the control group at the same period of time.
Figure 5Effect of Angelica gigas extract on protein expression (a) and mRNA expression (b) of Nrf2-regulated genes. AG, the extract of Angelica gigas treatment; HO-1, heme oxygenase-1; Nrf2, nuclear factor erythroid 2-related factor 2. p < 0.05 as compared with the control group at the same period of time.
Figure 6Comparison of the expression levels of Bax and Bcl-2 expression in the testicular tissue. (a) Western blot analysis of Bax and Bcl-2. (b) Densitometric analysis of Bax, Bcl-2, and Bax/Bcl-2 ratio relative to beta-actin. AG, the extract of Angelica gigas treatment. p < 0.05 as compared with the control group at the same period of time.